CWK CUSHMAN AND WAKEFIELD LTD
Financials · Russell 2000
Next earnings: not announced yet
What 11 analyst firms say about CUSHMAN AND WAKEFIELD LTD: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
11 rated views · 11 analyst/firm records · 11 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8042
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8052
Recent analyst activity · last 90 days
Our tracked history has 9 reports on CWK from 9 analyst firms in the last 90 days (11 firms in the past year).
Comparing each firm's latest target with its previous one: 2 left it unchanged and 4 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Brendan Lynch | Hold | 6 Aug 2026 | 16.00 USD |
| Citigroup | Nicholas Joseph | Buy | 22 Oct 2026 | 18.00 USD |
| Citizens JMP | Michell B Germain | Buy | 22 Oct 2026 | 16.00 USD |
| Goldman Sachs | Julien Blouin | Buy | 22 Oct 2026 | 17.00 USD |
| Jefferies | Joe Dickstein | Hold | 17 Aug 2026 | Conflicting reports · excluded |
| Morgan Stanley | Unnamed analyst | Buy | 22 Oct 2026 | 15.00 USD |
| Raymond James | Patrick J O'Shaughnessy | Buy | 21 Oct 2026 | — |
| UBS | Alex Kramm | Hold | 10 Aug 2026 | 15.00 USD |
| William Blair | Stephen Sheldon | Buy | 5 Aug 2026 | — |
| Wolfe Research | Andrew Rosivach | Buy | 9 Feb 2026 | 19.00 USD |
| Data feed RESEARCH | Research Team | Sell | 16 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:49 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.